FGEN - Fibrogen Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - FGEN (921299)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S71-1+1-0-1

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-09-14
FGENYu K PeonyChief Medical OfficerS - Sale$51.00-2,851185,546-2%-$145,401
2017-09-13
FGENRiggs Rory BDirS - Sale$51.92-25,0001,040,913-2%-$1,298,000
M
2017-09-13
FGENNeff Thomas BCEOS - Sale$51.67-38,6363,479,067-1%-$1,996,274
2017-09-11
FGENCotroneo PatVP, Finance, CFOS - Sale$49.45-2,851157,405-2%-$140,982
DM
2017-08-31
FGENRoutti JormaDirS - Sale+OE$47.35-12,000127,840-9%-$568,260
DM
2017-08-28
FGENNeff Thomas BCEOS - Sale+OE$43.73-38,6363,525,652-1%-$1,689,444
2017-08-21
FGENYu K PeonyChief Medical OfficerS - Sale$41.03-7,500191,507-4%-$307,725
D
2017-08-08
FGENYu K PeonyChief Medical OfficerS - Sale+OE$50.58-37,500199,007-16%-$1,896,861
D
2017-08-08
FGENCotroneo PatVP, Finance, CFOS - Sale+OE$50.61-95,000163,366-37%-$4,808,038
D
2017-08-01
FGENYu K PeonyChief Medical OfficerS - Sale+OE$33.48-10,000216,507-4%-$334,800
DM
2017-08-01
FGENCotroneo PatVP, Finance, CFOS - Sale+OE$33.97-28,346163,366-15%-$962,965
DM
2017-07-24
FGENNeff Thomas BCEOS - Sale+OE$35.09-38,6363,527,864-1%-$1,355,746
2017-07-17
FGENKurkijarvi KaleviDirS - Sale$33.45-2,00032,000-6%-$66,900
2017-07-10
FGENYu K PeonyChief Medical OfficerS - Sale$32.98-5,000216,507-2%-$164,900
DM
2017-07-06
FGENNeff Thomas BCEOS - Sale+OE$33.38-38,6363,528,700-1%-$1,289,547
D
2017-07-06
FGENCotroneo PatVP, Finance, CFOS - Sale+OE$34.00-4,000163,366-2%-$136,000
D
2017-06-22
FGENCotroneo PatVP, Finance, CFOS - Sale+OE$32.00-3,000163,366-2%-$96,000
DM
2017-06-21
FGENNeff Thomas BCEOS - Sale+OE$31.52-38,6363,529,536-1%-$1,217,645
D
2017-06-19
FGENCotroneo PatVP, Finance, CFOS - Sale+OE$30.00-5,500163,366-3%-$165,000
2017-06-15
FGENKurkijarvi KaleviDirS - Sale$28.50-2,00034,000-6%-$57,000
DM
2017-06-15
FGENNeff Thomas BCEOS - Sale+OE$29.40-38,6363,530,372-1%-$1,135,734
2017-06-14
FGENYu K PeonyChief Medical OfficerS - Sale$28.95-3,721221,507-2%-$107,723
2017-06-12
FGENCotroneo PatVP, Finance, CFOS - Sale$28.75-2,891163,366-2%-$83,116
DM
2017-06-09
FGENTamura ToshinariDirS - Sale+OE$28.89-30,00048,000-38%-$866,550
D
2017-06-06
FGENKearns Thomas F JrDirS - Sale+OE$28.71-18,000248,564-7%-$516,780
DM
2017-05-30
FGENNeff Thomas BCEOS - Sale+OE$26.21-38,6363,541,680-1%-$1,012,531
2017-05-16
FGENKurkijarvi KaleviDirS - Sale$27.40-2,00036,000-5%-$54,800
DM
2017-05-15
FGENNeff Thomas BCEOS - Sale+OE$27.70-38,6363,547,205-1%-$1,070,062
2017-05-10
FGENYu K PeonyChief Medical OfficerS - Sale$26.38-5,000226,046-2%-$131,890
D
2017-04-25
FGENYu K PeonyChief Medical OfficerS - Sale+OE$28.00-5,000231,046-2%-$140,0000+2
D
2017-04-25
FGENCotroneo PatVP, Finance, CFOS - Sale+OE$28.00-6,500157,905-4%-$182,0000+2
DM
2017-04-24
FGENNeff Thomas BCEOS - Sale+OE$26.92-38,6363,548,041-1%-$1,040,198+1+4
2017-04-17
FGENKurkijarvi KaleviDirS - Sale$25.25-2,00038,000-5%-$50,500+2+9
DM
2017-04-12
FGENNeff Thomas BCEOS - Sale+OE$24.79-38,6363,548,877-1%-$957,670-1+2
DM
2017-04-03
FGENNeff Thomas BCEOS - Sale+OE$23.92-38,6363,549,713-1%-$924,123-4+7+20
DM
2017-03-20
FGENNeff Thomas BCEOS - Sale+OE$24.34-38,6363,550,549-1%-$940,3050+1+5
2017-03-14
FGENYu K PeonyChief Medical OfficerS - Sale$25.41-7,851231,046-3%-$199,45800+1
DM
2017-03-14
FGENNeff Thomas BCEOS - Sale+OE$25.07-38,636368,160-9%-$968,47100+1
2017-03-10
FGENCotroneo PatVP, Finance, CFOS - Sale$25.30-7,851157,905-5%-$198,630+100
DM
2017-03-01
FGENCotroneo PatVP, Finance, CFOS - Sale+OE$26.00-6,500132,248-5%-$169,000-4+2-6
2017-02-16
FGENKurkijarvi KaleviDirS - Sale$24.45-2,00040,000-5%-$48,900-1-4+2
DM
2017-02-13
FGENNeff Thomas BCEOS - Sale+OE$23.94-38,6363,480,341-1%-$924,7650-2+3
DM
2017-02-08
FGENNeff Thomas BCEOS - Sale+OE$23.46-37,7983,481,177-1%-$886,7410+2+9
DM
2017-01-26
FGENNeff Thomas BCEO, 10%S - Sale+OE$23.29-37,7983,490,793-1%-$880,315-60+7
2017-01-19
FGENKurkijarvi KaleviDirS - Sale$24.90-2,00042,000-5%-$49,800-6-10-4
D
2017-01-11
FGENCotroneo PatVP, Finance, CFOS - Sale+OE$24.00-6,500132,248-5%-$156,000-70-6
DM
2017-01-11
FGENNeff Thomas BCEO, 10%S - Sale+OE$23.85-37,7983,500,409-1%-$901,522-70-6
2017-01-10
FGENYu K PeonyChief Medical OfficerS - Sale$23.56-5,000202,448-2%-$117,800+30-3
DM
2016-12-27
FGENNeff Thomas BCEO, 10%S - Sale+OE$20.74-37,7983,510,025-1%-$783,931-2+50
2016-12-16
FGENRiggs Rory BDirS - Sale$20.87-20,0001,065,913-2%-$417,310-2-4+21
2016-12-14
FGENYu K PeonyChief Medical OfficerS - Sale$20.65-2,344207,448-1%-$48,404-2-4+21
2016-12-12
FGENCotroneo PatVP, Finance, CFOS - Sale$22.05-2,344132,248-2%-$51,685+4-1+25
DM
2016-12-12
FGENNeff Thomas BCEO, 10%S - Sale+OE$21.24-37,7983,519,643-1%-$802,828+4-1+25
DM
2016-11-28
FGENNeff Thomas BCEO, 10%S - Sale+OE$22.80-37,7983,533,948-1%-$861,794-7+2-2
DM
2016-11-17
FGENKearns Thomas F JrDirS - Sale+OE$22.40-18,000270,564-6%-$403,1600+1-14
DM
2016-11-16
FGENNeff Thomas BCEO, 10%S - Sale+OE$22.29-37,7983,543,564-1%-$842,5170+1-14
DM
2016-10-31
FGENNeff Thomas BCEO, 10%S - Sale+OE$16.75-37,7983,553,180-1%-$633,305-2-4+33+71
DM
2016-10-18
FGENNeff Thomas BCEO, 10%S - Sale+OE$17.75-37,7983,562,796-1%-$670,915+2-3+25+50
DM
2016-10-03
FGENNeff Thomas BCEO, 10%S - Sale+OE$20.61-37,7983,572,412-1%-$779,017-3-6-21+11
DM
2016-09-20
FGENNeff Thomas BCEO, 10%S - Sale+OE$21.66-37,7983,582,028-1%-$818,70500-21+13
2016-09-14
FGENYu K PeonyChief Medical OfficerS - Sale$18.66-2,345206,502-1%-$43,7580+10-10+27
2016-09-12
FGENCotroneo PatVP, Finance, CFOS - Sale$18.22-2,345134,359-2%-$42,726+5+13-5+34
DM
2016-09-08
FGENNeff Thomas BCEO, 10%S - Sale+OE$18.98-37,7983,591,644-1%-$717,595+4+9+9+39
DM
2016-08-25
FGENNeff Thomas BCEO, 10%S - Sale+OE$17.80-37,7983,605,948-1%-$672,7050+1+27+41
DM
2016-07-26
FGENNeff Thomas BCEO, 10%S - Sale+OE$18.38-37,7983,615,564-1%-$694,548+1+6-7+23
M
2016-07-12
FGENNeff Thomas BCEO, 10%S - Sale$17.50-27,0003,625,180-1%-$472,419+3+6+11+43
M
2016-06-28
FGENNeff Thomas BCEO, 10%S - Sale$16.02-27,0003,652,180-1%-$432,574+2+4+17+27
M
2016-06-14
FGENNeff Thomas BCEO, 10%S - Sale$16.48-27,0003,679,180-1%-$444,960-4-5+5+26
2016-06-15
FGENCotroneo PatVP, Finance, CFOS - Sale$16.49-1,796138,114-1%-$29,616-4-5+5+26
2016-06-10
FGENYu K PeonyChief Medical OfficerS - Sale$17.96-2,344210,257-1%-$42,098-1-4+2+34
M
2016-06-02
FGENNeff Thomas BCEO, 10%S - Sale$18.98-27,0003,706,180-1%-$512,595+6-2-10+18
M
2016-05-19
FGENNeff Thomas BCEO, 10%S - Sale$17.68-27,0003,737,869-1%-$477,4240+2-12+22
2016-05-16
FGENYu K PeonyChief Medical OfficerS - Sale$17.60-6,107214,011-3%-$107,483-3+1-9+22
2016-05-16
FGENCotroneo PatVP, Finance, CFOS - Sale$17.60-6,107141,868-4%-$107,483-3+1-9+22
M
2016-05-02
FGENNeff Thomas BCEO, 10%S - Sale$17.78-27,0003,764,869-1%-$480,060-3-2+10-2
M
2016-04-19
FGENNeff Thomas BCEO, 10%S - Sale$19.98-27,0003,791,869-1%-$539,460+4+1-8-9
M
2016-04-04
FGENNeff Thomas BCEO, 10%S - Sale$21.11-27,0003,818,869-1%-$570,043+7-2-170
D
2016-04-01
FGENValone Frank H MdChief Medical OfficerS - Sale+OE$21.11-10,750108,684-9%-$226,941-1+1-12-3
M
2016-03-21
FGENNeff Thomas BCEO, 10%S - Sale$18.74-27,0003,845,869-1%-$505,872-2+4+3+12
M
2016-03-07
FGENNeff Thomas BCEO, 10%S - Sale$19.62-27,0003,872,869-1%-$529,6130+5+18-3
D
2016-03-01
FGENValone Frank H MdChief Medical OfficerS - Sale+OE$16.84-10,750112,605-9%-$181,040+4-1+14-6
DM
2016-02-22
FGENNeff Thomas BCEO, 10%S - Sale+OE$19.11-27,0003,908,423-1%-$515,850-1-3+2+3
D
2016-02-16
FGENValone Frank H MdChief Medical OfficerS - Sale+OE$18.41-10,750100,840-10%-$197,943+3-4-14-5
M
2016-02-09
FGENNeff Thomas BCEO, 10%S - Sale$15.31-27,0003,835,423-1%-$413,360+3+14+10+7
M
2016-01-28
FGENNeff Thomas BCEO, 10%S - Sale$19.41-27,0003,862,423-1%-$524,015-4-14-15-7
2016-01-21
FGENKearns Thomas F JrDirS - Sale$22.08-1,572270,564-1%-$34,710+1-10-7-15
M
2016-01-13
FGENNeff Thomas BCEO, 10%S - Sale$23.69-27,0003,889,423-1%-$639,683-5-7-16-22
M
2015-12-23
FGENKearns Thomas F JrDirS - Sale$30.88-7,800272,136-3%-$240,825+4+1-35-49
M
2015-12-22
FGENNeff Thomas BCEO, 10%S - Sale$30.10-27,0003,916,423-1%-$812,703-10-34-51
2015-12-15
FGENCotroneo PatVP, Finance, CFOS - Sale$28.95-837107,325-1%-$24,231-5+2-30-49
2015-12-10
FGENYu K PeonyVP, Clinical DevelopmentS - Sale$28.96-1,093176,595-1%-$31,653+1+6-13-39
M
2015-12-10
FGENNeff Thomas BCEO, 10%S - Sale$29.59-27,0003,943,423-1%-$798,815+1+6-13-39
D
2015-12-08
FGENMadero MiguelDirS - Sale+OE$30.49-40,386425,246-9%-$1,231,369-60-19-45
M
2015-11-25
FGENYu K PeonyVP, Clinical DevelopmentS - Sale$30.00-5,000178,345-3%-$150,0000+2+5-37
D
2015-11-25
FGENCotroneo PatVP, Finance, CFOS - Sale+OE$30.00-5,000107,775-4%-$150,0000+2+5-37
M
2015-11-23
FGENNeff Thomas BCEO, 10%S - Sale$28.49-27,0003,972,705-1%-$769,125+1+2+5-37
M
2015-11-23
FGENKearns Thomas F JrDirS - Sale$28.51-7,800279,936-3%-$222,389+1+2+5-37
2015-11-17
FGENYu K PeonyVP, Clinical DevelopmentS - Sale$28.00-5,000183,345-3%-$140,000-3+8+11-36
M
2015-11-09
FGENYu K PeonyVP, Clinical DevelopmentS - Sale$25.61-5,000187,904-3%-$128,075-6-3+7-36
D
2015-11-02
FGENValone Frank H MdChief Medical OfficerS - Sale+OE$23.18-10,00084,044-11%-$231,793-5+1+12-39

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top